1. Home
  2. SCPH vs BSII Comparison

SCPH vs BSII Comparison

Compare SCPH & BSII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SCPH
  • BSII
  • Stock Information
  • Founded
  • SCPH 2013
  • BSII 2024
  • Country
  • SCPH United States
  • BSII Hong Kong
  • Employees
  • SCPH N/A
  • BSII N/A
  • Industry
  • SCPH Biotechnology: Pharmaceutical Preparations
  • BSII
  • Sector
  • SCPH Health Care
  • BSII
  • Exchange
  • SCPH Nasdaq
  • BSII Nasdaq
  • Market Cap
  • SCPH 173.6M
  • BSII 192.2M
  • IPO Year
  • SCPH 2017
  • BSII 2024
  • Fundamental
  • Price
  • SCPH $2.57
  • BSII N/A
  • Analyst Decision
  • SCPH Strong Buy
  • BSII
  • Analyst Count
  • SCPH 3
  • BSII 0
  • Target Price
  • SCPH $14.00
  • BSII N/A
  • AVG Volume (30 Days)
  • SCPH 519.0K
  • BSII 7.2K
  • Earning Date
  • SCPH 05-13-2025
  • BSII 01-01-0001
  • Dividend Yield
  • SCPH N/A
  • BSII N/A
  • EPS Growth
  • SCPH N/A
  • BSII N/A
  • EPS
  • SCPH N/A
  • BSII N/A
  • Revenue
  • SCPH $36,332,000.00
  • BSII N/A
  • Revenue This Year
  • SCPH $114.00
  • BSII N/A
  • Revenue Next Year
  • SCPH $77.45
  • BSII N/A
  • P/E Ratio
  • SCPH N/A
  • BSII $105.03
  • Revenue Growth
  • SCPH 167.28
  • BSII N/A
  • 52 Week Low
  • SCPH $1.94
  • BSII $9.85
  • 52 Week High
  • SCPH $5.65
  • BSII $10.35
  • Technical
  • Relative Strength Index (RSI)
  • SCPH 47.35
  • BSII N/A
  • Support Level
  • SCPH $1.94
  • BSII N/A
  • Resistance Level
  • SCPH $2.71
  • BSII N/A
  • Average True Range (ATR)
  • SCPH 0.27
  • BSII 0.00
  • MACD
  • SCPH 0.04
  • BSII 0.00
  • Stochastic Oscillator
  • SCPH 76.36
  • BSII 0.00

About SCPH scPharmaceuticals Inc.

scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.

About BSII Black Spade Acquisition II Co Class A Ordinary Share

Black Spade Acquisition II Co is a blank check company.

Share on Social Networks: